Clinical Trial Update: Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating IMVT-1402 for generalized myasthenia gravis is currently recruiting to assess efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis Generalized

Drugs mentioned

• IMVT-1402

Snippet

Sponsor: Immunovant Sciences GmbH | Conditions: Generalized Myasthenia Gravis | Phase 3 | Status: RECRUITING